Introduction
Preeclampsia is a multi-factorial syndrome that occurs in the second half of pregnancy; it manifests with a triad of symptoms: swelling, proteinuria and hypertension, and in severe cases, convulsions and coma. [1] Despite the success in the study of the pathogenesis and etiology of preeclampsia, there is no single theory explaining the causes and the mechanism of its development; both being important for its diagnosis and prevention. [2, 3] It is believed that preeclampsia is caused by neurogenic, hormonal, genetic and immunological factors. [4, 5] Preeclampsia is considered a failure of body's adaptive mechanisms. 
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Compared to normal pregnancy, increased inflammatory responses are reported [10] [11] [12] and immune deviation toward T helper type 1 (Th1) in pregnancy with established preeclampsia. [13] Roberts [14] was one of the first who suggested that mediators released in preeclampsia are responsible for the endothelial damage. Injured endothelium initiates a dysfunctional cascade of coagulation, vasoconstriction and intravascular fluid redistribution; it results in the clinical syndrome of preeclampsia. [15] Numerous studies showed that the balance of cytokines had importance in the regulation of pregnancy. [16, 17] Diagnostic and prognostic significance of breaches in the immune balance during preeclampsia has not yet been determined. [17] Pro-inflammatory cytokines, such as IL-2, IL-8, TNF are increased in the blood, in leukocytes during preeclampsia (PE). Elevated concentrations of TNF-α have been observed in the blood of women with PE. [18] Compared to the increased level of pro-inflammatory cytokines, the blood level of some anti-inflammatory cytokines, as IL-4 and IL-10 [19] are decreased in patients with PE.
The purpose of this study was to evaluate the proinflammatory TNF-α, IL-1β, IL-8, and anti-inflammatory IL-10 cytokines and C-reactive protein (CRP) in moderate and severe preeclampsia, compared to normotensive pregnancies in the third trimester.
Methods
This study was designed as a prospective single-center study of pregnant women in their third trimester. Inclusion criteria were singleton pregnancy (between 28 and 40 weeks of gestation) and reproductive age. Exclusion criteria were acute and chronic genital and extra genital diseases (essential hypertension, heart failure, diabetes, morbid obesity, immunodeficiency, systemic diseases, chronic infectious diseases, genetic pathology). All patients signed the informed consent for the inclusion in the study. The study was approved by the Ethical Committee of our clinic.
Fifty patients with moderate or severe preeclampsia and 50 with normal pregnancy were included in this study. Patients were divided into two groups: those complicated by varying degrees of preeclampsia in the third trimester of gestation, and normotensive patients without threatening signs of hypertension and preeclampsia (control group).
The severity of preeclampsia was determined according to the definition of the World Health Organization, Handbook for guideline development, Geneva, 2010. Moderate or severe preeclampsia was diagnosed on the criteria for classification at the time of collection of maternal serum.
The level of IL-1β, TNF, IL-8, and IL-10 was determined through a commercial test. Cytokine level in the serum was measured by the "sandwich" method of solid-phase enzyme immunoassay using double antibody. Recombinant cytokines as part of the testwhale were used as a standard for comparison. The detection was done by "Victor" immunoassay analytics. According the standard samples titration, calibration graphs were made for each cytokine, as determined by their level in the range of detected concentrations (1-2000 pg/ml).
Data were analyzed using SPSS Statistics for Windows, version 13.0 (SPSS Inc., Chicago, IL, USA). Data are presented as means and percentages, standard deviations, and minimal and maximal values. The Mann-Whitney U test was used to evaluate betweengroup differences in results. A value p <0.05 was considered statistically significant.
Results
Our analysis showed that in pregnancy complicated by preeclampsia, cytokine levels essentially change compared with the respective levels in physiological pregnancy. Even a lighter form of preeclampsia shows directional change, i.e., elevated levels of pro-and antiinflammatory cytokines, with the exception of IL-10 that has a downward trend in severe preeclampsia. Table 1 shows statistical analysis of difference in age and gestational age. The difference in average age among pregnant women with medium and severe preeclampsia (29.9±4.7 versus 34.2±3.85) was statistically significant (p=0.004). Pregnant women from the examined groups differ slightly in terms of average length of gestational age, which ranges from 34.4±3.6 weeks in the group with severe PE, and 35.5±3.4 weeks in the group with symptoms of moderate PE (Fig. 1) .
With regards to the distribution by ethnicity, Albanians were often represented with 56% in the group with preeclampsia, or 44% with symptoms of medium, and 68% with symptoms of severe PE ( Table 1) . Pregnant Albanians in 68% dominated the normoten- Cytokines and C-reactive protein in moderate and severe preeclampsia 189 average values, the lowest and highest serum values of IL-8 in the analyzed groups are shown in Table 2 .
Statistical analysis did not confirm significant difference in the serum values of IL-10 among pregnant women with moderate preeclampsia and healthy pregnant women (p=0.5), but highly significant (p< 0.01) difference among moderate preeclampsia/severe preeclampsia/control group was due to the lower values of this interleukin in severe preeclampsia group, comparing moderate preeclampsia in relation to the control, and due to the highly significant lower values when comparing control in relation to moderate preeclampsia group ( Table 2) . Average concentrations of IL-10 in serum amounted to 23.2±40.7 pg/ml in group of preeclampsia, 45.5±48.4 pg/ml in the group of moderate preeclampsia, and 0.8±0.4 pg/ml in the group with severe preeclampsia. In normotensive group, average serum concentration of IL-10 was 4.2±6.7 pg/ml.
Patients with preeclampsia had significantly (p= 0.02) higher serum concentrations of IL-β compared to normotensive, owing to the highly significant (p<0.01) higher concentrations in the group of severe preeclampsia versus control group, while the difference observed in moderate form of preeclampsia and control group was statistically insignificant (p=0.5) ( Table 2 ). The difference between the two subgroups of preeclampsia was statistically significant (p=0.04). The lowest average value of IL-1β was 1.8±7.4 pg/ml, as recorded in the control group, with similar average values observed in the group with moderate preeclampsia, while the highest average value in the group with severe preeclampsia measured 11.3±35.7 pg/ml.
Mean levels of IL-8, IL-10 and IL-1β in patients with moderate and severe preeclampsia and control group are presented in Fig. 2 .
Both subgroups insignificantly (p=0.7) differed in terms of CRP values ( Table 3) . Significant difference p<0.01 was confirmed among pregnant women with PE, and pregnant women with moderate and severe PE in relation to healthy pregnant women. The average values of CRP in group of PE with severe range was recorded at around 12 mg/L, while in the group of healthy pregnant women an average of 4.7±4.6 mg/L was recorded (Fig. 3) .
Results of the analyzed differences between groups in terms of TNF-α values show that the serum of pregnant women in the group with secondary symptoms expressed in PE records such significantly higher values in pregnant women with PE compared with the control group (p=0.012) ( Table 3 ). TNF-α had an average value of 146.3±254.3 in the group of pregnant with PE, 206.6±300.9 in the group with moderate PE, and 86.1±184.3 in the group with severe PE, whereas the lowest average value of 58.3±243.4 was identified in the normotensive group. 
Discussion
Results of this research showed that the most of the changes in the concentration of pro-inflammatory cytokines are seen in moderate preeclampsia. In moderate preeclampsia there is increased synthesis of these cytokines and the level of IL-10 and IL-8 reaches maximum values. In severe preeclampsia the level of proinflammatory cytokines remained elevated or did not differ from the values characteristic of physiological pregnancy. Thus, the study showed that, according to the cytokine profile, levels of pro-inflammatory cytokines in pregnancies complicated by preeclampsia did not only increase, but they also amended the ratio of opposite pools coinciding with the results of other studies. However, changes in the level of cytokines determined by the degree of preeclampsia [20] [21] [22] [23] did not differ in our study from the dynamics identified in studies of other authors. [24] Thus, many researchers argue that the concentration of IL-1β significantly rises with the increasing severity of preeclampsia and reaches maximum values [25] during severe preeclampsia. [26] An analo- All PE: all preeclampsia groups; BMI: body mass index; CRP: C-reactive protein; TNF: tumor necrosis factor gous situation was the change in the concentration of other pro-inflammatory cytokines (IL-6 and TNF-α), which increased with the worsening of the disease. [27] They are both important mediators of the inflammatory and immune responses. These cytokines produce wide variety of effects on numerous cell types, including induction and suppression of the production of other cytokines, and many other factors including prostaglandins, platelet-activation factor and nitric oxide. [28] Some authors emphasize the increased synthesis of IL-2 in the third trimester of pregnancy complicated by preeclampsia, and significantly increase the proportions of TNF-α/IL-4 and IL-2/IL-4. [29] Based on the data obtained, they are coming to a conclusion about the prevalence of Th1 immune response in this pathology. A comparison of changes in cytokine profile with increasing severity of preeclampsia allow us to determine the levels of compensation of this pathological condition which reflect the degree of implementation and functional reserve of various mechanisms to maintain homeostasis. [30] The first phase of the changes seen in mild preeclampsia increases when creating of all studied cytokines except IL-4 and IL-10. The second phase the IL-1β and TNF-α starts to decrease ceding place to further increments in the level of IL-8 and IL-6, which suppress the inflammatory reaction and act as antagonists of IL-1β and TNF-α. During that period, the limiting role of IL-10 weakens and it is manifested through reduced levels when compared to values in normal pregnancy, giving testimony to the weakened compensatory mechanisms. The third phase, which can be called decompensated, characterized by the absence of significant differences in the level of IL-1β and IL-6, is comparable to the same level during normal pregnancy. This happens in the background of increased concentrations of other pro-inflammatory cytokines and reduced levels of the anti-inflammatory cytokines IL-4 and IL-10.
Statistical analysis confirmed a significant difference in average age between pregnant women with moderate and severe preeclampsia. Maternal age at the extremes (<20 and >40 years) has been identified as a risk factor for preeclampsia. [31] Maternal age (>35 years) is also associated with an increased risk for preeclampsia. Similar risk factors were observed in our study, where the elderly (>30 years), women are at greater risk for preeclampsia, both classified as moderate or severe preeclampsia.
CRP is a marker of tissue damage and inflammation. Maternal levels of CRP are elevated in overt preeclampsia, but there is still a debate about its usefulness as a predictive marker for preeclampsia during the first and second trimester of pregnancy. Similar findings have been made in a number of studies. Chunfang et al. [31] have reported that women with BMI ≤25 kg/m 2 and elevated CRP were associated with a 2.5 fold increased risk of preeclampsia, but no similar association was observed in overweight women. Wolf et al. [32] have reported that the first trimester CRP levels were significantly higher among women who developed preeclampsia.
In connection with the changes that the anti-inflammatory cytokine concentrations in severe preeclampsia caused in the opposite direction, moderate phase can be considered a critical stage in the complicated pregnancy that comes to most functional strain homeostatic system.
Conclusion
With increasing severity of the pathological process, the impact of regulatory factors that limit the systemic effect is reduced.
At a certain stage of this process there is a significant decrease in concentration of IL-4 and IL 10 in blood serum in women with severe preeclampsia, compared with other indicators in moderate preeclampsia that are increased. This is a major pathogenetic difference of severe preeclampsia and normal pregnancy.
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